Tag: Percutaneous Coronary Intervention (PCI)

Clopidogrel may be preferred over aspirin in high-risk patients after PCI

Presented By
Dr Joo-Yong Hahn, Sungkyunkwan University School of Medicine, South Korea
Trial
Phase 4, SMART-CHOICE 3
Conference
ACC 2025
Type
Peer-reviewed article

22 May 2025 14:25

Searching for the optimal duration of DAPT after PCI

Presented By
Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea
Trial
HOST-BR
Conference
ACC 2025
Type
Peer-reviewed article

22 May 2025 14:22

FLAVOUR II: Novel non-invasive PCI-guidance strategy non-inferior to standard-of-care

Presented By
Dr Jian’an Wang, Second Affiliated Hospital of Zhejiang University School of Medicine, China
Trial
FLAVOUR II
Conference
ACC 2025
Type
Peer-reviewed article

22 May 2025 14:03

Bioadaptor meets expectations in reducing target lesion failures in coronary artery disease

Presented By
Prof. David Erlinge, Lund University, Sweden
Trial
INFINITY-SWEDEHEART
Conference
ESC 2024
Type
Peer-reviewed article

7 November 2024 12:48

OCCUPI: OCT-guided PCI improves outcomes in complex CAD

Presented By
Prof. Byeong-Keuk Kim, Yonsei University Hospital, South Korea
Trial
OCCUPI
Conference
ESC 2024
Type
Peer-reviewed article

7 November 2024 12:39

NOTION-3: TAVI plus PCI improves outcomes in CAD plus severe aortic stenosis

Presented By
Dr Jacob Lønborg, Copenhagen University Hospital, Denmark
Trial
Phase 3, NOTION-3
Conference
ESC 2024
Type
Peer-reviewed article

7 November 2024 10:44

Preventive PCI of vulnerable intracoronary plaque leads to favourable outcomes

Presented By
Prof. Seung-Jung Park, University of Ulsan College of Medicine, South Korea
Trial
PREVENT
Conference
ACC 2024
Type
Peer-reviewed article

16 May 2024 14:52

IVUS-guided PCI beats angiography in patients with acute coronary syndrome

Presented By
Prof. Shao-Liang Chen, Nanjing Medical University, China
Trial
IVUS-ACS
Conference
ACC 2024
Type
Peer-reviewed article

16 May 2024 13:40

ACS: Necessary DAPT after PCI may be shorter than currently advised

Presented By
Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, NY, USA
Trial
ULTIMATE-DAPT
Conference
ACC 2024
Type
Peer-reviewed article

16 May 2024 13:29

ORBITA-2 confirms PCI effective for symptom relief in patients with stable angina 

Presented By
Dr Christopher Rajkumar, Imperial College London, UK
Trial
ORBITA-2
Conference
AHA 2023
Type
Peer-reviewed article

29 January 2024 13:48

Immediate or staged revascularisation in STEMI plus multivessel disease?

Presented By
Prof. Barbara Stähli, University of Zürich, Switzerland
Trial
MULTISTARS AMI
Conference
ESC 2023
Type
Peer-reviewed article

30 October 2023 16:07

Guidelines for Acute Coronary Syndrome

Presented By
Prof. Borja Ibañez; Prof. Maria Rubini Gimene; Dr John Coughlan; Prof. Margret Leosdottir
Conference
ESC 2023

30 October 2023 16:04

Can aspirin be omitted after PCI in patients with high bleeding risk?

Presented By
Dr Masahiro Natsuaki, Saga University, Japan
Trial
Phase 4, STOPDAPT-3
Conference
ESC 2023
Type
Peer-reviewed article

30 October 2023 16:03

Angiography vs OCT vs IVUS guidance for PCI: a network meta-analysis

Presented By
Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, USA
Conference
ESC 2023
Type
Peer-reviewed article

30 October 2023 16:02

OCTOBER trial: OCT-guided PCI improves clinical outcomes in bifurcation lesions

Presented By
Dr Lene Nyhus Andreasen, Aarhus University, Denmark
Trial
OCTOBER
Conference
ESC 2023
Type
Peer-reviewed article

30 October 2023 16:01

RENOVATE-COMPLEX-PCI results support intravascular-guided PCI for complex lesions

Presented By
Prof. Joo-Yong Hahn, Sungkyunkwan University School of Medicine, South Korea
Trial
RENOVATE-COMPLEX-PCI
Conference
ACC 2023
Type
Peer-reviewed article

7 June 2023 16:59

PCI not better than GDMT in severe ischaemic cardiomyopathy

Presented By
Prof. Divaka Perera, King's College London, UK
Trial
REVIVED-BCIS2
Conference
ACC 2023
Type
Peer-reviewed article

7 June 2023 10:05

Medical therapy versus PCI for ischaemic cardiomyopathy

Presented By
Prof. Divaka Perera, Guy's & St Thomas' NHS Foundation Trust, London, UK
Trial
REVIVED-BCIS2
Conference
ESC 2022
Type
Peer-reviewed article

27 October 2022 12:16

Conservative or invasive management for high-risk kidney disease patients with ischaemia?

Presented By
Prof. Sripal Bangalore, New York University School of Medicine, NY, USA
Trial
Phase 4, ISCHEMIA-CKD EXTEND
Conference
ESC 2022
Type
Peer-reviewed article

27 October 2022 12:10

Genotype-guided antiplatelet therapy in patients receiving PCI

Presented By
Dr Brenden Ingraham, Mayo Clinic, MN, USA
Trial
Phase 4, TAILOR-PCI
Conference
ESC 2022
Type
Peer-reviewed article

27 October 2022 12:06

FFR-guided decision-making in patients with AMI and multivessel disease

Presented By
Dr Joo-Yong Hahn, Samsung Medical Center, Seoul, South Korea
Trial
FRAME-AMI
Conference
ESC 2022
Type
Peer-reviewed article

27 October 2022 10:29

COMPLETE revascularisation improves angina-related QoL

Presented By
Prof. Shamir Mehta, McMaster University, Canada
Trial
COMPLETE
Conference
ACC 2022
Type
Peer-reviewed article

15 June 2022 14:24

Plot twist for negative FAME 3 results: early QoL benefits of PCI

Presented By
Dr Frederik Zimmermann, Catharina Hospital, the Netherlands
Trial
FAME 3
Conference
ACC 2022
Type
Peer-reviewed article

15 June 2022 14:19

No FLAVOUR difference between FFR and IVUS for PCI guidance

Presented By
Prof. Bon-Kwon Koo, Seoul National University College of Medicine, Korea
Trial
FLAVOUR
Conference
ACC 2022
Type
Peer-reviewed article

15 June 2022 13:49

2021 ESC Guidelines on Heart Failure

Presented By
Prof. Carolyn Lam, Duke-NUS Medical School, Singapore
Conference
ESC 2021
Type
Peer-reviewed article

26 October 2021 12:34

2021 ESC/EACTS Guidelines on Valvular Heart Disease

Presented By
Dr Victoria Delgado, Leiden University Medical Center, the Netherlands
Conference
ESC 2021
Type
Peer-reviewed article

26 October 2021 12:18

Men and women benefit equally from early aspirin withdrawal following PCI

Presented By
Dr Birgit Vogel, Icahn School of Medicine, USA
Trial
TWILIGHT
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 23:24

TALOS-AMI: Exploring outcomes after switching to clopidogrel versus ticagrelor at 1 month from MI

Presented By
Prof. Kiyuk Chang, Seoul St. Mary’s Hospital, South Korea
Trial
TALOS-AMI
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 20:46

Clopidogrel monotherapy associated with better net outcomes relative to aspirin monotherapy 6-18 months after PCI

Presented By
Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea
Trial
HOST-EXAM
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 19:52

Better outcomes with invasive strategy if anatomic complete revascularisation is possible

Presented By
Dr Gregg Stone, Mount Sinai Medical Centre, USA
Trial
ISCHEMIA
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 10:20

Ticagrelor not superior to clopidogrel after elective PCI

Presented By
Prof. Johanne Silvain, Sorbonne University, France
Trial
Phase 3, ALPHEUS
Conference
AHA 2020
Type
Peer-reviewed article

18 February 2021 10:43

PIONEER III trial: Drug-eluting stents comparable

Presented By
Prof. Alexandra Lansky, Yale School of Medicine, USA
Trial
PIONEER III
Conference
AHA 2020
Type
Peer-reviewed article

18 February 2021 10:30

Trimetazidine after successful PCI not associated with fewer cardiac events

Presented By
Prof. Roberto Ferrari, University of Ferrara, Italy
Trial
ATPCI trial
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 13:30

Fewer adverse events with ticagrelor monotherapy after 3 months DAPT

Presented By
Prof. Y.S. Jang, Yonsei University, South Korea
Trial
TICO
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 15:29

TWILIGHT sub-study: same outcomes for diabetes patients

Presented By
Prof. D. Angiolillo, University of Florida - Jacksonville, USA
Trial
TWILIGHT, TWILIGHT-DM
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 15:24

TWILIGHT sub-study: complex PCI patients

Presented By
Prof. G. Dangas, Icahn School of Medicine at Mount Sinai, USA
Trial
TWILIGHT
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 15:20

Finding the sweet spot of anticoagulation in AF patients with ACS

Presented By
Prof. Renato D. Lopes, Duke University School of Medicine, USA
Trial
AUGUSTUS
Conference
ISTH 2020
Type
Peer-reviewed article

8 September 2020 14:59

Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days

Presented By
Prof. J. Alexander, Duke University, USA
Trial
AUGUSTUS
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 14:06

PCI and CABG are equal in left main CAD

Presented By
Dr D.W. Park, Asan Medical School, South Korea
Trial
PRECOMBAT
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 12:45

TAILOR-PCI misses endpoint but still provides valuable insights

Presented By
Prof. N. Pereira, Mayo Clinic, USA
Trial
TAILOR-PCI
Conference
ACC 2020
Type
Peer-reviewed article

7 September 2020 23:16

Drop aspirin after 3 months in non-STEMI ACS patients on dual antiplatelet therapy

Presented By
Prof. Usman Baber, Icahn School of Medicine at Mount Sinai, USA
Trial
TWILIGHT
Conference
AHA 2019
Type
Peer-reviewed article

26 February 2020 20:58

Colchicine: no difference in peri-procedural cardiovascular events 30 days post-PCI

Presented By
Dr Binita Shah, NYU School of Medicine, USA
Trial
COLCHINE-PCI
Conference
AHA 2019
Type
Peer-reviewed article

26 February 2020 17:04

Intra-aortic balloon pump better than Impella: new observational data

Presented By
Dr Sanket S. Dhruva, University of California, San Francisco, USA
Conference
AHA 2019
Type
Peer-reviewed article

26 February 2020 15:06

Less bleeding and fewer hospitalisations with antithrombotic regimen with apixaban without aspirin

Trial
AUGUSTUS
Conference
ACC 2019
Type
Peer-reviewed article

4 June 2019 13:19
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com